Behavioural Pharmacology publishes original research reports in diverse areas, ranging from ethopharmacology to the pharmacology of schedule-controlled operant behaviour, provided that their primary focus is behavioural. Topics include drug, chemical, and hormonal effects on behaviour, the neurochemical mechanisms underlying behaviour, and behavioural methods for the study of drug action. Both animal and human studies are published. Studies reporting neurochemical data have a predominantly behavioural focus, and human studies do not consist exclusively of clinical trials or case reports. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool. Preference is given to studies that demonstrate and develop the potential of behavioural methods, and to papers reporting findings of direct relevance to clinical problems.

Editor
Paul Willner 
Department of Psychology 
University of Wales 
Swansea, Singleton Park 
Swansea SA2 8PP, UK 
Phone: +44-(0)1792 295844 
Fax: +44-(0)1792 295679 
p.willner@swansea.ac.uk

Associate Editors
Jack Bergman, PhD 
Harvard Medical School 
McLean Hospital 
115 Mill St 
Belmont, MA 02478-9106,USA 
jbergman@hms.harvard.edu
Louk Vanderschuren
Department of Animals in Science and Society
Faculty of Veterinary Medicine
Utrecht University
Yalelaan 2
3584 CM Utrecht
The Netherlands
L.J.M.J.Vanderschuren@uu.nl

Reviews Editor
Bart Ellenbroek 
Victoria University Wellington 
Wellington, New Zealand 
bart.ellenbroek@vuw.ac.nz

Assistant Editors – Reviews
Gernot Riedel 
University of Aberdeen 
Aberdeen, UK 
g.riedel@abdn.ac.uk
Viviana Trezza 
Roma Tre University 
Rome, Italy 
viviana.trezza@uniroma3.it
Benjamin Yee 
The Hong Kong Polytechnic University 
Hong Kong 
yee@hotmail.ch

Editorial Board
C Belzung 
Université François Rabelais
France
R J Beninger
Queen’s University
Kingston, Ontario, Canada
M E Cain
Kansas State University
Manhattan, KS, USA
J J Canales
University of Tasmania
Hobart, Australia
R M Craft
Washington State University
Pullman, WA, USA
J F Cryan
University College Cork
Cork, Ireland
T Duka
University of Sussex
Brighton, UK
H Einat
University of Minnesota 
Duluth, MN, USA
M B Gatch
UNT Health Science Center
Fort Worth, TX, USA
J W Grimm
Western Washington University,
Bellingham, WA, USA
F S Hall
The University of Toledo
Toledo, OH, USA
J. Haller
Institute of Experimental Medicine
Budapest, Hungary
J Homberg
Radboud University Nijmegen Medical Centre
Nijmegen, The Netherlands
E M Jutkiewicz
University of Michigan Medical School
MI, USA
K. Kantak
Boston University
Boston, MA, USA
W Koek
University of Texas Health Science 
at San Antonio
TX, USA
G F Koob
Scripps Clinic and Research Foundation
La Jolla, CA, USA
H Lesscher
Utrecht University
Utrecht, The Netherlands
J McGaughy
University of New Hampshire
Durham, NH, USA
D Morgan
University of Florida
FL, USA
A L Odum, 
Utah State University 
Logan, UT, USA
M W Oglesby
University of North Texas
Fort Worth, TX, USA
M F Olive
Arizona State University
AZ, USA
C Paronis
Harvard Medical School
Belmont, MA, USA
K Preston
NIDA Addiction Research Center 
Baltimore, MD, USA
T W Robbins 
University of Cambridge 
Cambridge, UK
R J Rodgers
University of Leeds
Leeds, UK
D Sanger
Sanofi-Aventis Research
Chilly-Mazarin, France
J Scheel-Kruger 
CFIN, Aarhus University &
PET-centre, Aarhus University Hospital
Aarhus, Denmark
W Spooren
F. Hoffmann-La Roche 
Basle, Switzerland
D N Stephens 
University of Sussex
Brighton, UK